397 related articles for article (PubMed ID: 16377540)
1. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
Josephson CD; Abshire TC
Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
[TBL] [Abstract][Full Text] [Related]
2. Emergency department care for patients with hemophilia and von Willebrand disease.
Singleton T; Kruse-Jarres R; Leissinger C
J Emerg Med; 2010 Aug; 39(2):158-65. PubMed ID: 18757163
[TBL] [Abstract][Full Text] [Related]
3. Progress in the treatment of bleeding disorders.
Bergman GE
Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836
[TBL] [Abstract][Full Text] [Related]
4. A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.
Berntorp E; Archey W; Auerswald G; Federici AB; Franchini M; Knaub S; Kreuz W; Lethagen S; Mannucci PM; Pollmann H; Scharrer I; Hoots K
Eur J Haematol Suppl; 2008 May; (70):3-35. PubMed ID: 18380871
[TBL] [Abstract][Full Text] [Related]
5. Plasma-derived biological medicines used to promote haemostasis.
Ofosu FA; Freedman J; Semple JW
Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
[TBL] [Abstract][Full Text] [Related]
6. Advances in clotting factor treatment for congenital hemorrhagic disorders.
Tarantino MD; Aledort LM
Clin Adv Hematol Oncol; 2004 Jun; 2(6):363-8. PubMed ID: 16163206
[TBL] [Abstract][Full Text] [Related]
7. Composition, quality control, and labeling of plasma-derived products for the treatment of von Willebrand disease.
Mazurier C
Semin Thromb Hemost; 2006 Jul; 32(5):529-36. PubMed ID: 16862527
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy reviews: clinical use of hemostatic agents.
Lowe GD; Lawson DH
Am J Hosp Pharm; 1978 Apr; 35(4):414-22. PubMed ID: 306196
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
10. Transfusion therapy in congenital coagulopathies.
Lusher JM
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.
Coppola A; Franchini M; Makris M; Santagostino E; Di Minno G; Mannucci PM
Haemophilia; 2012 May; 18(3):e173-87. PubMed ID: 22335611
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Berntorp E
Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
14. Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes.
Siegmund B; Richter H; Pollmann H
Haemophilia; 2007 Jan; 13(1):21-5. PubMed ID: 17212720
[TBL] [Abstract][Full Text] [Related]
15. Pioneering designs for recombinant coagulation factors.
Schulte S
Thromb Res; 2011; 128 Suppl 1():S9-12. PubMed ID: 22221848
[TBL] [Abstract][Full Text] [Related]
16. Management of von Willebrand disease in developing countries.
Mannucci PM
Semin Thromb Hemost; 2005 Nov; 31(5):602-9. PubMed ID: 16276468
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-transmitted infection in hemophilia in developing countries.
Yee TT; Lee CA
Semin Thromb Hemost; 2005 Nov; 31(5):527-37. PubMed ID: 16276461
[TBL] [Abstract][Full Text] [Related]
19. Current therapy for rare factor deficiencies.
Di Paola J; Nugent D; Young G
Haemophilia; 2001 Jan; 7 Suppl 1():16-22. PubMed ID: 11240614
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
